COVID-19 infection during pregnancy - maternal and perinatal outcomes: a tertiary care centre study


  • Nazia Hassan Department of Obstetrics and Gynecology, SKIMS, Medical College and Hospital, Srinagar, Jammu and Kashmir, India
  • Mudasir Muzamil Department of Cardiology, SKIMS Soura Srinagar, Jammu and Kashmir, India
  • Dawood Banday Department of Medicine, SKIMS, Soura, Srinagar, Jammu and Kashmir, India



Coronavirus-2019, COVID-19, Polymerase chain reaction, Pregnancy, Pregnant women


Background: With the exponential increase in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) worldwide, an increasing proportion of pregnant women are now infected during their pregnancy. The knowledge gained from previous human coronavirus outbreaks suggests that pregnant women and their fetuses are particularly susceptible to poor outcomes. The aim of this study was to summarize the maternal and perinatal outcomes of pregnant women infected with COVID-19 during their pregnancy.

Methods: Eligibility criteria included pregnant women positive for COVID-19 as detected by real-time polymerase chain reaction (PCR) or dual fluorescence PCR-confirmed SARS-CoV-2 infection.

Results: A total of 38 pregnant women positive for COVID-19 as confirmed by RT-PCR, were included in the study. 21% cases had preterm deliveries and LSCS was the preferred mode of delivery in 23 of 38 i.e., 60.5% cases. There was a tendency for low Apgar score at birth, higher rates of fetal distress, meconium, NICU admissions. There was one IUD and one neonatal death. The treatment patterns of COVID-19 infection among pregnant women during their pregnancy or following delivery was mostly supportive in the form of oxygen and antibiotic therapy.

Conclusions: Although the majority of mothers were discharged without any major complications, severe maternal morbidity as a result of COVID-19 and perinatal deaths were reported. Vertical transmission of the COVID-19 could not be ruled out. Pregnant infected women had different symptoms, and they were given mostly supportive treatments than the general infected population. Careful monitoring of pregnancies with COVID-19 and measures to prevent neonatal infection are warranted.


Li Q, Guan X, Wu, P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.

Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191:292-7.

Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature. J Microbiol Immunol Infect. 2019;52:501-3.

O’Day MP. Cardio-respiratory physiological adaptation of pregnancy. Semin Perinatol. 1997;21:268-75.

Tsafaras GP, Ntontsi P, Xanthou G. Advantages and limitations of the neonatal immune system. Front Pediatr. 2020;8:5.

Steinbuch, Y. Chinese baby tests positive for coronavirus 30 hours after birth. Available at: Accessed on 9th February 2020.

Woodward, A. A pregnant mother infected with the coronavirus gave birth, and her baby tested positive 30 hours later. Available at: -in-infant-bornfrom-infected-mother-2020-2. Accessed on 8th February 2020.

Gillespie, T. Coronavirus: doctors fear pregnant women can pass on illness after newborn baby is diagnosed. Available at: on-illness-after-newborn-baby-is-diagnosed-11926968. Accessed on 8th February 2020.

Science Media Centre. Expert Reaction to Newborn Baby Testing Positive for Coronavirus in Wuhan. Available at: expert-reaction-to-newborn-baby-testing-positivefor- coronavirus-in-wuhan/. Accessed on 9th February 2020.

Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4.

Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to viral infection: an immunological viewpoint?. J Reprod Immunol. 2020:103122.

Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-7.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

Bastola A, Sah R, Rodriguez-Morales AJ, Lal BK, Jha R, Ojha HC, et al., The first 2019 novel coronavirus case in Nepal. Lancet Infect Dis. 2020;20(3):279-80.

Cheng SC, Chang YC, Chiang YL, Chien YC, Cheng M, Yang CH, et al. First case of Coronavirus disease 2019 (COVID-19) pneumonia in Taiwan. J Formosan Med Assoc. 2020;119(3):747-51.

Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. 2020;382(10):929-36.

Kim JY, Choe PG, Oh Y, Oh KJ, Kim J, Park SJ, et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci. 2020;35(5).

Silverstein WK Stroud L, Cleghorn GE, Leis JA. First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia. Lancet. 2020;395(10225):734.

Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: focus on pregnant women and children. J Infect. 2020;11:11.

Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translat Pediatr. 2020;9(1):51-60.

Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. Am J Roentgenol. 2020:1-6.

Gautret P, Lagier JC, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrobial Agents. 2020:105949.

Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G. Pregnancy outcome following first trimester exposure to chloroquine. Am J Perinatol. 1991;8(3):174-8.

American academy of pediatrics committee on drugs. Transfer of drugs and other chemicals into human milk. Pediatr. 2001;108(3):776.

Boelaert JR, Yaro S, Augustijns P, Meda N, Schneider YJ, Schols D, et al. Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1. Aids. 2001;15(16):2205-7.

De Brouwere V, Dubourg D, Richard F, Van Lerberghe W. Need for caesarean sections in west Africa. Lancet. 2002;359(9310):974-5.

Khan MN, Islam MM, Shariff AA, Alam MM, Rahman MM. Socio-demographic predictors and average annual rates of caesarean section in Bangladesh between 2004 and 2014. PloS One. 2017;12(5):e0177579.

Sharma D, Spearman P, The impact of cesarean delivery on transmission of infectious agents to the neonate. Clin Perinatol. 2008;35(2):407-20.






Original Research Articles